Cyclacel Pharmaceuticals
Stock Forecast, Prediction & Price Target
Cyclacel Pharmaceuticals (CYCC) stock Price Target by analysts
$1
Potential downside: -86.71%
Cyclacel Pharmaceuticals price prediction
What is Cyclacel Pharmaceuticals stock analysts` prediction?
Cyclacel Pharmaceuticals stock forecast: Based on 1 Wall Street analysts` predicted price targets for Cyclacel Pharmaceuticals in the last 3 months, the avarage price target is $1, with a high forecast of $NaN. The average price target represents a -86.71% change from the last price of $7.53.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Cyclacel Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Cyclacel Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jonathan Aschoff Roth Capital | 0% 0/1 | 11 months ago | $1 -86.71% downside | $1.14 | TheFly | Previous targets (0) |
Cyclacel Pharmaceuticals Financial Estimates
Cyclacel Pharmaceuticals Revenue Estimates
Cyclacel Pharmaceuticals EBITDA Estimates
Cyclacel Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $420K 0% | Avg: $50K Low: $50K High: $50K avg. -88.09% | Avg: $20.03M Low: $20.03M High: $20.03M avg. 39978% | Avg: $109.10M Low: $109.10M High: $109.10M avg. 444.46% | Avg: $159.91M Low: $159.91M High: $159.91M avg. 46.56% |
Net Income
% change YoY
| $-18.88M N/A | $-21.19M -12.23% | $-22.55M -6.40% | Avg: $-14.30M Low: $-5.92M High: $-1.43M avg. 36.55% | Avg: $2.17M Low: $161.65K High: $161.65K avg. 115.21% | Avg: $6.60M Low: $6.60M High: $6.60M avg. 203.27% | Avg: $10.04M Low: $10.04M High: $10.04M avg. 52.19% |
EBITDA
% change YoY
| $-22.98M N/A | $-27.88M -21.35% | $-25.42M 8.84% | Avg: $30K Low: $30K High: $30K avg. 100.11% | Avg: $12.02M Low: $12.02M High: $12.02M avg. 39978% | Avg: $65.46M Low: $65.46M High: $65.46M avg. 444.46% | Avg: $95.94M Low: $95.94M High: $95.94M avg. 46.56% |
EPS
% change YoY
| -$31.74 N/A | -$32.23 -1.54% | -$26.75 17.00% | Avg: -$4.33 Low: -$6.96 High: -$1.69 avg. 83.83% | Avg: $0.19 Low: $0.19 High: $0.19 avg. 104.39% | Avg: $7.76 Low: $7.76 High: $7.76 avg. 3984.21% | Avg: $11.81 Low: $11.81 High: $11.81 avg. 52.19% |
Operating Expenses
% change YoY
| $22.93M N/A | $27.65M 20.56% | $25.87M -6.44% | Avg: $199.95K Low: $199.95K High: $199.95K avg. -99.22% | Avg: $80.13M Low: $80.13M High: $80.13M avg. 39978.07% | Avg: $436.31M Low: $436.31M High: $436.31M avg. 444.46% | Avg: $639.50M Low: $639.50M High: $639.50M avg. 46.56% |
FAQ
What is Cyclacel Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 101.80% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -5.92M, average is -14.30M and high is -1.43M.
What is Cyclacel Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 10095.23% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $50K, average is $50K and high is $50K.
What is Cyclacel Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 1056.15% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$6.96, average is -$4.33 and high is $-1.69.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Cyclacel Pharmaceuticals stock. The most successful analyst is Jonathan Aschoff.